Promising New Treatment to Prevent Multidrug-Resistant Tuberculosis
Dick Menzies, Andrea Benedetti, and colleagues show that the antibiotic levofloxacin could significantly reduce the risk of MDR-TB.
View posts, news, and publications related to this research theme below.
Dick Menzies, Andrea Benedetti, and colleagues show that the antibiotic levofloxacin could significantly reduce the risk of MDR-TB.
Work by Irah King has uncovered a previously unknown role of fungi in shaping intestinal immunity.
Maziar Divangahi and James Martin uncover a natural flu defense that activates in the nasal cavity during pregnancy
Kevin Schwartzman received the McGill University Department of Medicine Mentor of the Year Award for 2024. Congrats!
New CIHR Clinical Trial Grant awarded to Dick Menzies: An adaptive trial to identify the safest regimen with the shortest duration for TB prevention
Congratulations to all RESP members who were funded in the Spring 2024 CIHR Project Grant Competition!
Publication by Dao Nguyen suggests that Pseudomonas aeruginosa might persist intracellularly
Members of the RESP program are leading the Department of Medicine’s world class teams in Tuberculosis and pulmonary fibrosis.
Congratulations to Deborah Assayag, Sushmita Pamidi, and Andrea Benedetti for their FRQS salary award!
Jonathon Campbell receives rhe Union-North America Region Early Career Investigator Award for his work on TB.